Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1
-
Narrated by:
-
By:
About this listen
Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma.
NCPD information and select publications here.
What listeners say about Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.